Theraclion S.A.
TCLIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $830 | $1,822 | $1,235 | $1,481 |
| % Growth | -54.5% | 47.5% | -16.6% | – |
| Cost of Goods Sold | $8,013 | $2,903 | $4,286 | $6,021 |
| Gross Profit | -$7,183 | -$1,080 | -$3,050 | -$4,540 |
| % Margin | -865.4% | -59.3% | -246.9% | -306.5% |
| R&D Expenses | $0 | $0 | $4,300 | $3,820 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $968 | $0 | $3,102 | $224 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,964 | $2,072 | -$4,145 | -$904 |
| Operating Expenses | $3,932 | $2,072 | $3,257 | $3,140 |
| Operating Income | -$6,960 | -$3,154 | -$6,307 | -$4,535 |
| % Margin | -838.6% | -173.1% | -510.5% | -306.2% |
| Other Income/Exp. Net | $78 | -$1,570 | $2,345 | -$108 |
| Pre-Tax Income | -$6,741 | -$4,724 | -$3,963 | -$4,643 |
| Tax Expense | -$984 | -$1,049 | $1,001 | -$883 |
| Net Income | -$5,757 | -$3,675 | -$4,964 | -$3,760 |
| % Margin | -693.6% | -201.7% | -401.8% | -253.9% |
| EPS | -0.12 | -0.08 | -0.17 | -0.17 |
| % Growth | -49.3% | 52.7% | 0% | – |
| EPS Diluted | -0.12 | -0.076 | -0.17 | -0.17 |
| Weighted Avg Shares Out | 46,093 | 45,732 | 29,388 | 22,769 |
| Weighted Avg Shares Out Dil | 46,093 | 48,276 | 29,388 | 22,769 |
| Supplemental Information | – | – | – | – |
| Interest Income | $49 | $31 | $44 | $74 |
| Interest Expense | $0 | $31 | $44 | $136 |
| Depreciation & Amortization | -$220 | $205 | $182 | $131 |
| EBITDA | -$6,960 | -$4,487 | -$6,126 | -$4,404 |
| % Margin | -838.6% | -246.3% | -495.8% | -297.4% |